Skip to content
NewsBlazeIN – Lifestyle
Author:
Aura Biosciences, Inc.
Aura Biosciences Reports Third Quarter 2026 Financial Results and Recent Business Highlights
November 9, 2026
Aura Biosciences to Participate in Upcoming Investor Conference
November 3, 2026
Aura Biosciences to Participate in Upcoming Investor Conference
September 2, 2026
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 1, 2026
Aura Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 11, 2026
Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors
July 8, 2026
Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma
June 1, 2026
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 19, 2026
Aura Biosciences to Participate in Upcoming Investor Conferences
May 12, 2026